The upcoming global debut is set to mark a step forward in AI-powered hematology, advancing the 4th Generation of Hematology Analysis Ozelle will unveil O-Cyte 1, our newest automated hematology analyzer, at ADLM 2026 in Anaheim, California. Making its global debut at one of the leading international events for diagnostics and laboratory medicine, O-Cyte 1 […]
For more than seventy years, hematology analysis has advanced through successive technological breakthroughs. From automated cell counting to multi-parameter flow cytometry and digital morphology, each generation of innovation has expanded how laboratories observe and understand blood. Yet one of the most information-rich dimensions of hematology has remained difficult to scale: cellular morphology. For decades, identifying
The Fourth Generation of Hematology Analysis Has Begun Weiterlesen »
Why supply planning now matters as much as analyzer selection For many years, laboratory managers focused first on choosing analyzers and only later on the details of laboratory and analytical supplies. Today, this approach is no longer sustainable. Test cartridges, reagents, calibrators and quality‑control (QC) materials account for a large share of total cost of
How to Plan Laboratory and Analytical Supplies for AI Mini‑Lab Analyzers Weiterlesen »
Ozelle has received a Gold Award at the German Innovation Award, one of Germany’s leading innovation honors, for its EHBT-50 Mini Lab Multi-Functional Analyzer. The award recognizes innovations that advance products and technologies through meaningful user value, engineering excellence, and practical impact across industries. Advancing Diagnostics Beyond Centralized Laboratories Designed for decentralized clinical settings, the
Across the Middle East and Eurasia, diagnostics is entering a decisive new phase — driven by rising testing demand, chronic disease burdens, and a strong push toward connected, value‑based care. Laboratories and clinics are under increasing pressure to deliver faster, smarter, and more standardized results while keeping costs and staffing under control. At Expomed Eurasia
Ozelle to Showcase AI‑Powered Hematology Analyzers at Expomed Eurasia 2026 Weiterlesen »
When Installed Base Becomes the Growth Challenge Across many veterinary markets today, hematology analyzers are already widely installed in clinics. For one veterinary diagnostics distributor operating across several EMEA markets, this reality created an unexpected commercial challenge. For years, the distributor had built a successful business supplying hematology analyzers to small animal clinics. But by
In the rapidly evolving field of regenerative therapies, precision and consistency are everything. For a leading U.S. medical device company specializing in autologous platelet and stem cell concentration systems, platelet-rich plasma (PRP) therapy represents both a science and a promise — accelerating recovery by harnessing the body’s innate regenerative power. Yet its success hinges on
Bei der heutigen Eröffnung der WHX Labs Dubai 2026 können Besucher am Stand S1.D58 sehen, wie Ozelle diagnostische Tests in interaktive, entscheidungsfähige Workflows verwandelt. Unter dem Motto “AI × CBM: The Next-Generation of Complete Blood Morphology” kombiniert das integrierte System hochauflösende Morphologie-Analysen, KI-gestützte Workflows und szenarioreife Panels für eine sichere klinische Entscheidungsfindung, angetrieben durch eine
Auf der WHX Labs Dubai 2026 (10.-13. Februar, Stand S1.D58) wird Ozelle sein intelligentes Diagnosesystem der nächsten Generation unter dem Motto “AI × CBM: The Next Generation of Complete Blood Morphology” vorstellen. Die Lösung von Ozelle wurde entwickelt, um diagnostische Tests über eigenständige Analysegeräte hinaus zu ermöglichen. Sie integriert KI-gestützte Blutmorphologie-Analysen mit einer szenarioreifen Systemarchitektur und verbindet so analytische Tiefe in Laborqualität mit
Ozelle bringt KI-gestützte, szenarioreife Diagnostik zu WHX Labs Dubai 2026 Weiterlesen »
Siehe Jenseits des Blutes. Einblicke in die Zukunft. Düsseldorf, Deutschland - 17. November 2025 Auf der MEDICA 2025 (Halle 1 | A23-H) stellt Ozelle seine AI + Complete Blood Morphology (CBM)-Lösung der nächsten Generation vor, eine innovative All-in-One-Diagnostik, die Hämatologie, Biochemie und Immunoassay-Tests in einem einzigen Durchgang kombiniert. Die neue Lösung verkörpert die Vision von Ozelle, fortschrittliche
Geben Sie Ihre E-Mail-Adresse ein und wir senden Ihnen einen Bestätigungscode zu, mit dem Sie Ihr Passwort zurücksetzen können.
Deutsch 
English 
Français 
Русский 
Español 
Português 
العربية 
Italiano